VKORC1 and CYP2C9 genetic polymorphisms in hepatic or portal vein thrombosis

Thromb Res. 2010 Aug;126(2):e134-6. doi: 10.1016/j.thromres.2010.03.015.
No abstract available

MeSH terms

  • Adult
  • Anticoagulants / therapeutic use
  • Aryl Hydrocarbon Hydroxylases / genetics*
  • Budd-Chiari Syndrome / drug therapy
  • Budd-Chiari Syndrome / genetics*
  • Cohort Studies
  • Cytochrome P-450 CYP2C9
  • Female
  • Humans
  • Male
  • Middle Aged
  • Mixed Function Oxygenases / genetics*
  • Polymorphism, Genetic*
  • Vitamin K / antagonists & inhibitors
  • Vitamin K Epoxide Reductases

Substances

  • Anticoagulants
  • Vitamin K
  • Mixed Function Oxygenases
  • CYP2C9 protein, human
  • Cytochrome P-450 CYP2C9
  • Aryl Hydrocarbon Hydroxylases
  • VKORC1 protein, human
  • Vitamin K Epoxide Reductases